## Most Common HCV Genotype in India **Key Point:** **HCV genotype 3** is the most prevalent genotype in India, accounting for approximately **50–60%** of all HCV infections, followed by genotype 1 (20–30%). ### Global and Regional HCV Genotype Distribution | Genotype | Global Prevalence | India Prevalence | Geographic Distribution | Notes | |----------|-------------------|------------------|-------------------------|-------| | **1** | 46% | 20–30% | North America, Europe, Japan | Most common worldwide | | **2** | 13% | <5% | West Africa, USA | Rare in India | | **3** | 30% | **50–60%** | **South Asia (India, Pakistan)** | **Most common in India** | | **4** | 8% | <5% | Middle East, North Africa | Rare in India | | **5** | 1% | <1% | South Africa | Very rare globally | | **6** | 1% | <1% | Southeast Asia | Rare in India | **High-Yield:** The **Indian subcontinent is an epidemiological hotspot for HCV genotype 3**, driven by: - High prevalence of intravenous drug use - Unsafe blood transfusion practices (historically) - Nosocomial transmission via contaminated needles ### Clinical Significance of Genotype 3 1. **Treatment response:** Better response to direct-acting antivirals (DAAs) compared to genotype 1 - Sofosbuvir + velpatasvir: >95% SVR (sustained virological response) - Sofosbuvir + daclatasvir: >95% SVR 2. **Fibrosis progression:** Genotype 3 is associated with **more aggressive fibrosis** and higher risk of cirrhosis and hepatocellular carcinoma (HCC) 3. **Viral kinetics:** Genotype 3 has **higher viral replication rate** and faster disease progression compared to genotype 1 **Clinical Pearl:** In an Indian patient with HCV, assume **genotype 3 until proven otherwise**. This has implications for treatment selection and prognostic counseling. **Mnemonic:** **"3 in India"** — Genotype 3 is the most common in the Indian subcontinent.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.